Life Quality and Compliance After Transplant: The Case of Turkey

Basit Öğe Kaydı
dc.authoridKorkmaz, Medet/0000-0002-9894-9331
dc.authorwosidKorkmaz, Medet/GZK-8340-2022
dc.contributor.authorGuzel, H.
dc.contributor.authorKorkmaz, M.
dc.date.accessioned2024-08-04T20:45:56Z
dc.date.available2024-08-04T20:45:56Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description12th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- OCT 18-21, 2018 -- Trabzon, TURKEYen_US
dc.description.abstractObjective. Chronic renal failure is one of the most significant health problems in Turkey, as it is all over the world, and negatively affects quality of life. The aim of this study is to find factors affecting compliance levels and quality of life of patients undergoing kidney transplant. Materials and methods. The population of the study consisted of 244 patients who underwent kidney transplant. Although the study aimed to cover the entire target population in the sampling selection, it was conducted among 206 patients. The data were collected by face-to-face interview. Results. Of the patients, 92.7% were between 46 and 59 years of age, 54.4% had a living donor transplant, 54.9% had adverse effects, and 2.9% had rejection due to incompatibility. There was a significant relationship between compliance and quality of life; increasing frequency of adverse effects would decrease in direct proportion to compliance, which would, therefore, increase quality of life. All the subscale scores of the 36-Item Short Form Health Survey were found to have an average of 60 and above. The mean of the compliance scale was 48.33 (SD, 3.21), and, with the maximum score at 55, the mean of the group was high. In our country, patients view transplant as a final and definite treatment method. This might be related to fact that the longer the time after transplant, the lower the level of compliance.en_US
dc.description.sponsorshipTurkish Transplantat Ctr Coordinat Assocen_US
dc.identifier.doi10.1016/j.transproceed.2019.01.083
dc.identifier.endpage1037en_US
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue4en_US
dc.identifier.pmid31101166en_US
dc.identifier.scopus2-s2.0-85065569639en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1029en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2019.01.083
dc.identifier.urihttps://hdl.handle.net/11616/98791
dc.identifier.volume51en_US
dc.identifier.wosWOS:000500179300006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOf-Lifeen_US
dc.subjectMedication Adherenceen_US
dc.subjectKidney-Transplantationen_US
dc.subjectImmunosuppressive Medicationen_US
dc.subjectRenal-Transplantationen_US
dc.subjectChronic-Diseaseen_US
dc.subjectNonadherenceen_US
dc.subjectNoncomplianceen_US
dc.subjectPatienten_US
dc.subjectLiveren_US
dc.titleLife Quality and Compliance After Transplant: The Case of Turkeyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu